Correction to: A Phase II Study Evaluating Combined ... - Springer Link

4 downloads 0 Views 362KB Size Report
Maria José Méndez-Vidal12 & Carlos López2 & Inmaculada Ruiz de Mena13 & Josep ... Department of Medical Oncology, H. Miguel Servet, Paseo Isabel la.
Targeted Oncology _#####################_ https://doi.org/10.1007/s11523-017-0544-z

CORRECTION

Correction to: A Phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients Maria Alsina 1 & Fernando Rivera 2 & Francisco Javier Ramos 1 & Maica Galán 3 & Rafael López 4 & Pilar García-Alfonso 5 & José Enrique Alés-Martinez 6,7 & Bernardo Queralt 8 & Antonio Antón 9 & Alfredo Carrato 10 & Cristina Grávalos 11 & Maria José Méndez-Vidal 12 & Carlos López 2 & Inmaculada Ruiz de Mena 13 & Josep Tabernero 1 & Jordi Giralt 14 & Enrique Aranda 12 & on behalf of the Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD) and Grupo de Investigación Clínica en Oncología Radioterápica (GICOR)

# Springer International Publishing AG, part of Springer Nature 2017

Correction to: Targ Oncol https://doi.org/10.1007/s11523-017-0536-z Errors were subsequently identified in the article and the following corrections should be noted:

should read: A Phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients. The original article was corrected.

The title of the article, which previously read BCetuximab/ TPF/radiotherapy in oesophageal cancer^

The online version of the original article can be found at https://doi.org/ 10.1007/s11523-017-0536-z * Maria Alsina [email protected]

7

Spain and H Nuestra Sra Sonsoles, C/ Avda. Juan Carlos I, Avila, Spain

1

8

Department of Medical Oncology, H. JosepTrueta (ICO), Avinguda de França, Girona, Spain

9

Department of Medical Oncology, H. Miguel Servet, Paseo Isabel la Católica, 1-3, Zaragoza, Spain

Department of Medical Oncology, H.U. Marqués Valdecilla, Av. Valdecilla, 25 Santander, Spain

10

Department of Medical Oncology, H. Ramón y Cajal, Ctra. Colmenar Viejo, km. 9, 100 Madrid, Spain

Department of Medical Oncology, ICO Hospitalet, Avinguda de la Granvia, 199-203 Barcelona, Spain

11

Department of Medical Oncology, H. 12 de Octubre, Avenida de Córdoba, Madrid, Spain

12

Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, Department of Medical Oncology, University of Córdoba, CIBERONC, Instituto de Salud Carlos III, Av. Menendez Pida, Cordoba, Spain

13

TTD Group, Madrid, Spain

14

Department of Radiation Oncology, Vall d’Hebron University Hospital, Passeig de la Vall d’Hebron, 119-129 Barcelona, Spain

2

3

4

5

6

Vall d’Hebron University Hospital, Department of Medical Oncology, and Vall d’Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Passeig de la Vall d’Hebron, 119-129 Barcelona, Spain

Medical Oncology Department and Translational Medical Oncology Group, University Clinical Hospital and Health Research Institute (IDIS); CIBERONC, Santiago de Compostela University School of Medicine, Santiago de Compostela, Spain Department of Medical Oncology, H. Gregorio Marañón, Calle del Dr. Esquerdo, 46, Madrid, Spain Department of Medical Oncology, H. Ruber Internacional, Calle de la Masó, 38, Madrid, Spain